: Novavax’s stock pops after WHO grants its COVID-19 vaccine emergency-use listing

Novavax’s protein-based vaccine can now be offered to all 194 member nations of the WHO, as well as Unicef and other agencies.

Previous post Europe Markets: EasyJet and Rolls-Royce shares gain altitude as post-pandemic recoveries take flight
Next post : Micron raised profit and revenue guidance, but stock takes a dive